Company's Chief Movement Officer, Arnold Schwarzenegger, Will Be Presidential Guest Speaker
WARSAW, Ind. , Feb. 23, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment...
Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance
The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call
With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month.
/Zimmer%20Biomet%20Holdings%20Inc%20phone%20and%20logo-by%20viewimage%20via%20Shutterstock.jpg)
Zimmer Biomet has trailed the broader market over the past year, and it continues to face skeptical sentiment from analysts regarding its near- to medium-term growth outlook.
ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum
Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations